Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)
Webinar on

Multiple Myeloma: Opportunities and Challenges in the Changing Treatment Landscape

15th November, 2024

6:30pm IST | 4:OOpm EEST | 9:00am EST

In this webinar, you will get to know:

  • The latest treatment paradigms for first-line therapy in transplant-eligible patients
  • Evolving strategies for first-line therapy in transplant-ineligible patients
  • Second-line treatment breakthroughs, including the resurgence of Belantamab Mafodotin
  • Innovative endpoints in the design of multiple myeloma clinical trials
  • Key opportunities and challenges in managing relapse and refractory disease

Speaker

speaker
Dr. Stavros Gkolfinopoulos

(Associate Director, Global Safety Physician)

Dr. Stavros Gkolfinopoulos is the Associate Director, Global Safety Physician for the European division of Veeda Group. With nearly 13 years of experience as a Medical Oncologist, clinical trials investigator, and clinical scientist, he has worked in hospitals, cancer centers, and CROs, focusing on the clinical development of anticancer drugs. He holds a Master's in Neoplastic Diseases (High Honors), an MBA in Healthcare Management (High Honors), and was awarded First-in-Class honors from the Hellenic Academy of Oncology. Dr. Gkolfinopoulos has authored 53 publications and specializes in the medical management of solid and hematologic malignancies, drug development, clinical trials, safety signal identification, and risk mitigation strategies. He also has experience in health economics, with a thesis on the cost-effectiveness of a novel targeted agent for breast cancer.

Register for webinar now!